Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology. Read more about Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.
Current state of pediatric neuro-oncology imaging, challenges and future directions. Read more about Current state of pediatric neuro-oncology imaging, challenges and future directions.
Interdisciplinary care of children with diffuse midline glioma. Read more about Interdisciplinary care of children with diffuse midline glioma.
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. Read more about The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Read more about The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells. Read more about Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells.
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. Read more about Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance. Read more about Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. Read more about Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer. Read more about Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
